“…The cross-linking hydrogel has low toxicity, high water-retention capacity, multifunctional usefulness, and excellent biocompatibility [ 35 , 36 ], and has been applied in several biomedical research fields such as drug release [ 37 , 38 ], cell culture [ 39 ], tissue regeneration [ 40 – 42 ], 3D bioprinting [ 43 ], and prevention of postoperative intra-abdominal adhesion [ 44 ]. In the field of ophthalmology, cross-linking hydrogel has been used in tissue engineering, including corneal transplant [ 45 , 46 ] and retinal progenitor cell transplantation [ 47 ], drug delivery systems for multiple eye diseases such as glaucoma [ 48 ] and uveitis treatment [ 49 ], treatment of ocular surface [ 50 ] and lacrimal diseases [ 51 ], and substitution of the vitreous body [ 52 , 53 ], showing great potential. It was reported that a hydrogel based on thiol-modified derivatives of hyaluronic acid can become gelated at room temperature and be modulated in both gel compliance and gelation time by adjusting the ratio of its components [ 54 , 55 ].…”